Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	tigecycline cefoperazone/sulbactam carbapenems β-lactam antibiotics coagulation disorders hypofibrinogenaemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1365927/full

Internet